134 related articles for article (PubMed ID: 33880703)
1. Current Spectrum of Infections in Patients with X-Linked Agammaglobulinemia.
Paccoud O; Mahlaoui N; Moshous D; Aguilar C; Neven B; Lanternier F; Suarez F; Picard C; Fischer A; Blanche S; Lecuit M; Hermine O; Lortholary O;
J Clin Immunol; 2021 Aug; 41(6):1266-1271. PubMed ID: 33880703
[TBL] [Abstract][Full Text] [Related]
2. Serial Serum Immunoglobulin G (IgG) Trough Levels in Patients with X-linked Agammaglobulinemia on Replacement Therapy with Intravenous Immunoglobulin: Its Correlation with Infections in Indian Children.
Suri D; Bhattad S; Sharma A; Gupta A; Rawat A; Sehgal S; Singh S; Gupta S
J Clin Immunol; 2017 Apr; 37(3):311-318. PubMed ID: 28321612
[TBL] [Abstract][Full Text] [Related]
3. Early and prolonged intravenous immunoglobulin replacement therapy in childhood agammaglobulinemia: a retrospective survey of 31 patients.
Quartier P; Debré M; De Blic J; de Sauverzac R; Sayegh N; Jabado N; Haddad E; Blanche S; Casanova JL; Smith CI; Le Deist F; de Saint Basile G; Fischer A
J Pediatr; 1999 May; 134(5):589-96. PubMed ID: 10228295
[TBL] [Abstract][Full Text] [Related]
4. Functional Antibody Responses Following Allogeneic Stem Cell Transplantation for
van Zelm MC; Pumar M; Shuttleworth P; Aui PM; Smart JM; Grigg A; Bosco JJ
Front Immunol; 2019; 10():895. PubMed ID: 31105705
[TBL] [Abstract][Full Text] [Related]
5. [Intravenous immunoglobulin replacement therapy in 114 cases of congenital agammaglobulinemia].
Li YW; Chen H; Zhang Y; An YF; Tang XM; Zhao XD; Zhang ZY
Zhonghua Er Ke Za Zhi; 2021 Jun; 59(6):495-500. PubMed ID: 34102824
[No Abstract] [Full Text] [Related]
6. [X-linked agammaglobulinemia: experience in a Portuguese hospital].
Fernandes A; Guedes M; Vasconcelos J; Neves E; Fernandes S; Marques L
An Pediatr (Barc); 2015 Mar; 82(3):166-71. PubMed ID: 25443324
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of immunoglobulin replacement therapy on clinical outcome in patients with primary antibody deficiencies: results from a multicenter prospective cohort study.
Quinti I; Soresina A; Guerra A; Rondelli R; Spadaro G; Agostini C; Milito C; Trombetta AC; Visentini M; Martini H; Plebani A; Fiorilli M;
J Clin Immunol; 2011 Jun; 31(3):315-22. PubMed ID: 21365217
[TBL] [Abstract][Full Text] [Related]
8. [Intravenous immunoglobulin replacement therapy in X-linked agammaglobulinemia].
Kanegane H; Nomura K; Futatani T; Miyawaki T
Nihon Rinsho Meneki Gakkai Kaishi; 2002 Aug; 25(4):337-43. PubMed ID: 16583740
[TBL] [Abstract][Full Text] [Related]
9. Distinct Clinical Features and Novel Mutations in Taiwanese Patients With X-Linked Agammaglobulinemia.
Yeh YH; Hsieh MY; Lee WI; Huang JL; Chen LC; Yeh KW; Ou LS; Yao TC; Wu CY; Lin SJ
Front Immunol; 2020; 11():2001. PubMed ID: 33013854
[No Abstract] [Full Text] [Related]
10. Efficacy and safety of Gammaplex(®) 5% in children and adolescents with primary immunodeficiency diseases.
Melamed IR; Gupta S; Stratford Bobbitt M; Hyland N; Moy JN
Clin Exp Immunol; 2016 May; 184(2):228-36. PubMed ID: 26696596
[TBL] [Abstract][Full Text] [Related]
11. Clinical and Genetic Study of X-linked Agammaglobulinemia Patients (The Benefit of Early Diagnosis).
Alizadeh Z; Dashti P; Mazinani M; Nourizadeh M; Shakerian L; Tajik S; Movahedi M; Mamishi S; Pourpak Z; Fazlollahi MR
Iran J Allergy Asthma Immunol; 2020 Jun; 19(3):305-309. PubMed ID: 32615664
[TBL] [Abstract][Full Text] [Related]
12. [Immunoglobulin replacement therapy contribution in agammaglobulinemia: 10 case reports].
Ksouri H; Mellouli F; Barbouch R; Ben Hassen A; Béjaoui M
Arch Pediatr; 2006 Jul; 13(7):1034-9. PubMed ID: 16713207
[TBL] [Abstract][Full Text] [Related]
13. Toll-like receptor signaling is impaired in dendritic cells from patients with X-linked agammaglobulinemia.
Taneichi H; Kanegane H; Sira MM; Futatani T; Agematsu K; Sako M; Kaneko H; Kondo N; Kaisho T; Miyawaki T
Clin Immunol; 2008 Feb; 126(2):148-54. PubMed ID: 18271077
[TBL] [Abstract][Full Text] [Related]
14. A Novel
Han SP; Lin YF; Weng HY; Tsai SF; Fu LS
Front Immunol; 2019; 10():1953. PubMed ID: 31481959
[TBL] [Abstract][Full Text] [Related]
15. High- vs low-dose immunoglobulin therapy in the long-term treatment of X-linked agammaglobulinemia.
Liese JG; Wintergerst U; Tympner KD; Belohradsky BH
Am J Dis Child; 1992 Mar; 146(3):335-9. PubMed ID: 1543181
[TBL] [Abstract][Full Text] [Related]
16. A Multicentre Study on the Efficacy, Safety and Pharmacokinetics of IqYmune®, a Highly Purified 10% Liquid Intravenous Immunoglobulin, in Patients with Primary Immune Deficiency.
Krivan G; Chernyshova L; Kostyuchenko L; Lange A; Nyul Z; Derfalvi B; Musial J; Bellon A; Kappler M; Sadoun A; Bernatowska E
J Clin Immunol; 2017 Aug; 37(6):539-547. PubMed ID: 28711959
[TBL] [Abstract][Full Text] [Related]
17. Clinical and laboratory observation on immunoglobulin replacement therapy switching from an intravenous to a subcutaneous route in a Malaysian X-linked agammaglobulinemia patient.
Adli A; Wahab AA; Abdul Latiff AH; Ismail IH; Faizah MZ; Boekhren KB; Noh LM
Med J Malaysia; 2022 Jan; 77(1):95-97. PubMed ID: 35087003
[TBL] [Abstract][Full Text] [Related]
18. X-linked agammaglobulinemia in a 10-year-old boy with a novel non-invariant splice-site mutation in Btk gene.
Maekawa K; Yamada M; Okura Y; Sato Y; Yamada Y; Kawamura N; Ariga T
Blood Cells Mol Dis; 2010 Apr; 44(4):300-4. PubMed ID: 20122858
[TBL] [Abstract][Full Text] [Related]
19. X-linked agammaglobulinemia: a survey of 33 Iranian patients.
Moin M; Aghamohammadi A; Farhoudi A; Pourpak Z; Rezaei N; Movahedi M; Gharagozlou M; Ghazi BM; Zahed A; Abolmaali K; Mahmoudi M; Emami L; Bashashati M
Immunol Invest; 2004 Feb; 33(1):81-93. PubMed ID: 15015835
[TBL] [Abstract][Full Text] [Related]
20. Clinical characteristics and prenatal diagnosis for 22 families in Henan Province of China with X-linked agammaglobulinemia (XLA) related to Bruton's tyrosine kinase (BTK) gene mutations.
Gao S; Hu S; Duan H; Wang L; Kong X
BMC Med Genet; 2020 Jun; 21(1):131. PubMed ID: 32552675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
